:

Homeland Security

Emergent BioSolutions Acquires VaxGen’s Anthrax Vaccine Technology

DDN

Wednesday, May 14th, 2008

SHARE:

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone payments. The arrangement also includes specified percentages of future net sales. VaxGen's original $877 million contract to develop and produce a next-generation anthrax vaccine was terminated by the Department of Health and Human Services in December 2006 due to stability issues with the…

Army

Lawmakers Request DoD Briefing On Army’s Planned Cuts To Aviation Procurement

A bipartisan group of House lawmakers has sent a letter asking the Pentagon for a briefing on the potential industrial base impacts as a result of the Army’s planned cuts […]

Congress

CENTCOM Looking To Lessons Learned From Use Of LUCAS Drones

U.S Central Command (CENTCOM) is looking to lessons learned from its use of Low-cost Unmanned Combat Attack System (LUCAS) drones by Phoenix-based SpektreWorks, according to CENTCOM head Adm. Brad Cooper. […]

Army

Hegseth Says DoD Open To Reviewing Army’s Planned Cuts To Legacy Helicopter Procurement

Defense Secretary Pete Hegseth has told lawmakers the Pentagon is open to reviewing the Army’s planned procurement cuts to its legacy manned aviation fleet. Rep. Rosa DeLauro (D-Conn.), ranking member […]

Congress

Appropriators Press For Details On Iran War Costs; DoD’s $29B Estimate Doesn’t Include Base Damage

The Pentagon estimates the U.S.’ ongoing conflict with Iran has now cost at least $29 billion, while a lead official noted the updated figure does not factor in damage to […]